National Biotechnology Initiative Act of 2025

Administrative law and regulatory procedures

Cited source text, amounts, lobbyists, and targets

Subjects (14)

Advanced technology and technological innovations

Advisory bodies

Biological and life sciences

Congressional oversight

Data collection, sharing, protection

Employment and training programs

Executive Office of the President

Actions (2)

April 9, 2025

Referred to the Committee on Science, Space, and Technology, and in addition to the Committees on Foreign Affairs, Agriculture, Energy and Commerce, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

April 9, 2025

Introduced in House

Congress.gov source codes: 1000, Intro-H

Committees

Committee	Chamber	Activity	Date
Education and Workforce Committee	House	Referred To	April 9, 2025
Energy and Commerce Committee	House	Referred To	April 9, 2025
Agriculture Committee	House	Referred To	April 9, 2025
Foreign Affairs Committee	House

Text Versions

Version	Date	Links
Introduced in House	April 9, 2025	XML

Cosponsors (23)

Name	Party	State
Ami Bera	Democratic	CA
April McClain Delaney	Democratic	MD
Brad Finstad	Republican	MN

Related Bills (1)

Bill	Congress	Relationship
S 1387	119th	Identical bill

Similar Bills (AI)

Bills with similar content found using semantic analysis.

1387

119th

100%

National Biotechnology Initiative Act of 2025

238

119th

81%

Healthy Technology Act of 2025

2697

119th

81%

National Biotechnology Safety Act

Sources: Congress.gov

Show 21 more cited filings

AMERICAN ALLIANCE FOR BIOMANUFACTURINGclient→CASSIDY & ASSOCIATES, INC.

2026 · third_quarter · Science/Technology

ANNA KARAKITSOS PETER STAHLEY RYAN MULVENON

Cited source text, amounts, lobbyists, and targets

biomanufacturing and technology S.4781 - Make More in America Act of 2026 S.1387 - National Biotechnology Initiative Act of 2025 H.R.2756 - National Biotechnology Initiative Act of 2025

Client expense: Not reported · Firm income: $60,000

H.R.2756

Government targets: HOUSE OF REPRESENTATIVES, SENATE

NOVOZYMES NORTH AMERICA, INC.client→NOVOZYMES NORTH AMERICA, INC.

2026 · second_quarter · Agriculture

Cited source text, amounts, lobbyists, and targets

Issues related to sustainability, animal feed additives, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, biological products in agriculture, biotechnology and biological products, including the National Biotechnology Initiative Act of 2025 (H.R. 2756/S. 1387), and issues related to dietary supplements including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to nutrition, FDA regulation of feed ingredients, and agricultural biotechnology.

Client expense: $140,000 · Firm income: Not reported

H.R. 2756

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

ARCHER DANIELS MIDLAND COMPANYclient→ARCHER DANIELS MIDLAND COMPANY

2026 · second_quarter · Manufacturing

mr MATTHEW O'MARA ms MARIA PICA KARP

Cited source text, amounts, lobbyists, and targets

H.R. 2756: National Biotechnology Initiative Act of 2025; provisions related to biomanufacturing H.R. 8800: National Defense Authorization Act for Fiscal Year 2027; provisions related to biomanufacturing S. 1387: National Biotechnology Initiative Act of 2025; provisions related to biomanufacturing S. ____: National Defense Authorization Act, 2027; provisions related to biomanufacturing P.L. 119-60 (S. 1071): National Defense Authorization Act for Fiscal Year 2026; provisions related to biomanufacturing Discussions related to biomanufacturing, and supply chain for amino acids and vitamins

Client expense: $1,500,000 · Firm income: Not reported

H.R. 2756

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, White House Office

WITH HONOR ACTION, INC.client→WITH HONOR ACTION, INC.

2026 · second_quarter · Science/Technology

JARED SMITH KAYLAN SWARTZ

Cited source text, amounts, lobbyists, and targets

H.R.2756/S.1387, National Biotechnology Initiative Act of 2025 H.R.1604/S.754, Farm and Food Cybersecurity Act H.R.2109/S.1018, The Cybersecurity for Rural Water Systems Act of 2025 Issues related to biotechnology research, development, and manufacturing

Client expense: $140,000 · Firm income: Not reported

H.R.2756

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

AMERICAN SOCIETY FOR MICROBIOLOGYclient→AMERICAN SOCIETY FOR MICROBIOLOGY

2026 · second_quarter · Science/Technology

Cited source text, amounts, lobbyists, and targets

Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235); Cloud Labs to Advance Biotechnology Act of 2025 (S. 2676);

Client expense: $50,000 · Firm income: Not reported

H.R. 2756

Government targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICAN ALLIANCE FOR BIOMANUFACTURINGclient→CASSIDY & ASSOCIATES, INC.

2026 · second_quarter · Manufacturing

ANNA KARAKITSOS PETER STAHLEY RYAN MULVENON

Cited source text, amounts, lobbyists, and targets

biomanufacturing and technology S.4781 - Make More in America Act of 2026 S.1387 - National Biotechnology Initiative Act of 2025 H.R.2756 - National Biotechnology Initiative Act of 2025

Client expense: Not reported · Firm income: $60,000

H.R.2756

Government targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICAN ALLIANCE FOR BIOMANUFACTURINGclient→CASSIDY & ASSOCIATES, INC.

2026 · second_quarter · Science/Technology

ANNA KARAKITSOS PETER STAHLEY RYAN MULVENON

Cited source text, amounts, lobbyists, and targets

biomanufacturing and technology S.4781 - Make More in America Act of 2026 S.1387 - National Biotechnology Initiative Act of 2025 H.R.2756 - National Biotechnology Initiative Act of 2025

Client expense: Not reported · Firm income: $60,000

H.R.2756

Government targets: HOUSE OF REPRESENTATIVES, SENATE

ARCHER DANIELS MIDLAND COMPANYclient→ARCHER DANIELS MIDLAND COMPANY

2026 · first_quarter · Manufacturing

mr MATTHEW O'MARA ms MARIA PICA KARP

Cited source text, amounts, lobbyists, and targets

H.R. 2756: National Biotechnology Initiative Act of 2025; provisions related to biomanufacturing S. 1387: National Biotechnology Initiative Act of 2025; provisions related to biomanufacturing P.L. 119-60 (S. 1071): National Defense Authorization Act for Fiscal Year 2026; provisions related to biomanufacturing Discussions related to biomanufacturing, and supply chain for amino acids and vitamins Discussions related to biomanufacturing and competitiveness of U.S. production of animal feed ingredients

Client expense: $2,050,000 · Firm income: Not reported

H.R. 2756

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, White House Office

WITH HONOR ACTION, INC.client→WITH HONOR ACTION, INC.

2026 · first_quarter · Science/Technology

JARED SMITH KAYLAN SWARTZ

Cited source text, amounts, lobbyists, and targets

H.R.2756/S.1387, National Biotechnology Initiative Act of 2025 S.3597, National Quantum Initiative Reauthorization Act of 2026 Issues related to biotechnology research, development, and manufacturing

Client expense: $50,000 · Firm income: Not reported

H.R.2756

Government targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICAN SOCIETY FOR MICROBIOLOGYclient→AMERICAN SOCIETY FOR MICROBIOLOGY

2026 · first_quarter · Science/Technology

Cited source text, amounts, lobbyists, and targets

Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235); Cloud Labs to Advance Biotechnology Act of 2025 (S. 2676);

Client expense: $50,000 · Firm income: Not reported

H.R. 2756

Government targets: HOUSE OF REPRESENTATIVES, SENATE

NOVOZYMES NORTH AMERICA, INC.client→NOVOZYMES NORTH AMERICA, INC.

2026 · first_quarter · Agriculture

Cited source text, amounts, lobbyists, and targets

Issues related to sustainability - no specific legislation. Issues related to animal feed additives, sustainability, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, and biological product in agriculture - no specific legislation. Issues related to biotechnology and biological products including H.R.2756/S.1387 - National Biotechnology Initiative Act of 2025. H.R. 7366 - Dietary Supplement Regulatory Uniformity Act - Issues related to dietary supplements.

Client expense: $220,000 · Firm income: Not reported

H.R.2756

Government targets: HOUSE OF REPRESENTATIVES, SENATE

ARCHER DANIELS MIDLAND COMPANYclient→ARCHER DANIELS MIDLAND COMPANY

2025 · fourth_quarter · Manufacturing

Cited source text, amounts, lobbyists, and targets

H.R. 2756: National Biotechnology Initiative Act of 2025; provisions related to biomanufacturing S. 1387: National Biotechnology Initiative Act of 2025; provisions related to biomanufacturing P.L. 119-60 (S. 1071): National Defense Authorization Act for Fiscal Year 2026; provisions related to biomanufacturing Discussions related to biomanufacturing, and supply chain for amino acids and vitamins

Client expense: $1,320,000 · Firm income: Not reported

H.R. 2756

mr MATTHEW O'MARA

Government targets: HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, White House Office

WITH HONOR ACTION, INC.client→WITH HONOR ACTION, INC.

2025 · fourth_quarter · Science/Technology

Cited source text, amounts, lobbyists, and targets

H.R.1604/S.754, Farm and Food Cybersecurity Act H.R.2109/S.1018, The Cybersecurity for Rural Water Systems Act of 2025 H.R.2756/S.1387, National Biotechnology Initiative Act of 2025 Issues related to biotechnology research, development, and manufacturing

Client expense: $60,000 · Firm income: Not reported

H.R.2756

KAYLAN SWARTZ

Government targets: HOUSE OF REPRESENTATIVES, SENATE

NOVOZYMES NORTH AMERICA, INC.client→NOVOZYMES NORTH AMERICA, INC.

2025 · fourth_quarter · Agriculture

Cited source text, amounts, lobbyists, and targets

Issues related to sustainability - no specific legislation. Issues related to animal feed additives, sustainability, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, and biological product in agriculture - no specific legislation. Issues related to biotechnology and biological products including H.R.2756/S.1387 - National Biotechnology Initiative Act of 2025. Issues related to dietary supplements - no specific legislation.

Client expense: $150,000 · Firm income: Not reported

H.R.2756

Government targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICAN SOCIETY FOR MICROBIOLOGYclient→AMERICAN SOCIETY FOR MICROBIOLOGY

2025 · fourth_quarter · Science/Technology

Cited source text, amounts, lobbyists, and targets

Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235).

Client expense: $50,000 · Firm income: Not reported

H.R. 2756

Government targets: HOUSE OF REPRESENTATIVES, SENATE

WITH HONOR ACTION, INC.client→WITH HONOR ACTION, INC.

2025 · third_quarter · Science/Technology

DAVID MCCLINTOCK KAYLAN SWARTZ

Cited source text, amounts, lobbyists, and targets

H.R.1604/S.754, Farm and Food Cybersecurity Act H.R.2109/S.1018, The Cybersecurity for Rural Water Systems Act of 2025 H.R.2756/S.1387, National Biotechnology Initiative Act of 2025 Issues related to biotechnology research, development, and manufacturing (David Sean McClintock only lobbied the U.S. House of Representatives)

Client expense: $70,000 · Firm income: Not reported

H.R.2756

Government targets: HOUSE OF REPRESENTATIVES, SENATE

NOVOZYMES NORTH AMERICA, INC.client→NOVOZYMES NORTH AMERICA, INC.

2025 · third_quarter · Clean Air and Water (quality)

Cited source text, amounts, lobbyists, and targets

Issues related to biotechnology and biological products including H.R.2756 - National Biotechnology Initiative Act of 2025. H.R. 1346/S. 593 - Nationwide Consumer and Fuel Retailer Choice Act of 2025 and H.R. 4864/S. 2591 - Ethanol for America Act of 2025 - Issues related to biofuels industry expansion.

Client expense: $210,000 · Firm income: Not reported

H.R.2756

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

AMERICAN SOCIETY FOR MICROBIOLOGYclient→AMERICAN SOCIETY FOR MICROBIOLOGY

2025 · third_quarter · Science/Technology

Cited source text, amounts, lobbyists, and targets

Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235).

Client expense: $50,000 · Firm income: Not reported

H.R. 2756

Government targets: HOUSE OF REPRESENTATIVES, SENATE

WITH HONOR ACTION, INC.client→WITH HONOR ACTION, INC.

2025 · second_quarter · Science/Technology

BRIAN LE DAVID MCCLINTOCK KAYLAN SWARTZ

Cited source text, amounts, lobbyists, and targets

H.R.1604/S.754, Farm and Food Cybersecurity Act H.R.2109/S.1018, The Cybersecurity for Rural Water Systems Act of 2025 H.R.2756/S.1387, National Biotechnology Initiative Act of 2025 Issues related to biotechnology research, development, and manufacturing (David Sean McClintock only lobbied the U.S. House of Representatives)

Client expense: $80,000 · Firm income: Not reported

H.R.2756

Government targets: HOUSE OF REPRESENTATIVES, SENATE

NOVOZYMES NORTH AMERICA, INC.client→NOVOZYMES NORTH AMERICA, INC.

2025 · second_quarter · Agriculture

CATE THORIN ms SAVANNAH BONFITTO

Cited source text, amounts, lobbyists, and targets

Issues related to sustainability - no specific legislation. Issues related to biotechnology and biological products including H.R.2756 - National Biotechnology Initiative Act of 2025. Issues related to animal feed additives, sustainability, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, and biological product in agriculture - no specific legislation. Issues related to funding for Codex Allmentarius (Food Guide) - no specific legislation.

Client expense: $270,000 · Firm income: Not reported

H.R.2756

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE

AMERICAN SOCIETY FOR MICROBIOLOGYclient→AMERICAN SOCIETY FOR MICROBIOLOGY

2025 · second_quarter · Science/Technology

Cited source text, amounts, lobbyists, and targets

Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235).

Client expense: $50,000 · Firm income: Not reported

H.R. 2756